Development of the Parkinson’s Disease Medication Adherence Scale (PD-MAS)
Objective: To implement the first 3 phases of the scale development process that will create the PD-MAS. Background: Drug therapy is a central strategy in…Anodic stimulation reduces corticospinal tract engagement in STN-DBS for Parkinson’s disease: a case report.
Objective: To seek how novel programming options modify the therapeutic window in a case of off-targeting DBS. Background: In Parkinson’s disease deep brain stimulation (DBS)…DBS Directional programming – Institution based study of programming in PD and ET patients
Objective: To examine the use of Deep Brain Stimulation (DBS) directional programming in Parkinson Disease (PD) and Essential Tremor (ET) patients Background: DBS and its utility…Metadata standards to support deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease (PD)
Objective: A metadata framework for Digital Health Technologies (DHT) to support enhanced regulatory maturity, and to facilitate standardization and harmonization of data collection Background: DHTs…Effect of dopaminergic treatment on digital sensor features in Phase II PASADENA Part 1 in early Parkinson’s disease
Objective: To characterize the sensitivity of smartphone and -watch sensor features to levodopa and dopamine agonist (DA-Tx) treatment. Background: Digital health technology tools (DHTTs) enable…Determining the content of a clinician-rated tool for freezing of gait severity
Objective: This study aimed to determine clinician’s ratings of the most important triggering circumstances to be examined and aspects of freezing of gait (FOG) to…Diagnostic accuracy in an incidence cohort of Parkinson’s disease
Objective: To determine the accuracy of clinical diagnosis and research diagnostic criteria in a population-representative cohort of Parkinson's disease (PD) against a neuropathological gold standard…The COVID-19 Pandemic Impact on Advanced Parkinson’s Disease in the US
Objective: Characterize the risk of seven acute medical events in persons with advanced Parkinson’s disease (PD) using real world data before and within 12 months…Does Macronutrient dietary Intake of patients with Parkinson disease correlates with the cognitive function (MoCA)?
Objective: Analyze the correlation between macronutrient dietary intake and cognitive function of patients with Parkinson’s Disease Background: Several studies have shown that implementing a healthy…Challenges around end-of-life care for people with Parkinson’s disease in Kenya
Objective: To explore how people living with Parkinson’s disease (PwP), and their families, in Kenya negotiate the end of life. Background: Parkinson’s disease (PD) is…
- « Previous Page
- 1
- …
- 330
- 331
- 332
- 333
- 334
- …
- 338
- Next Page »